New study results show that patients have higher treatment satisfaction with liraglutide compared to exenatide

Submitted by on Thu, 10/22/2009 - 17:05

Montreal, Canada – New data on patient treatment satisfaction from the LEAD™ 6 trial presented today at the 20th World Diabetes Congress (International Diabetes Federation) shows that patients have higher overall treatment satisfaction with liraglutide than they do with exenatide.